TSC22D3 and Miyoshi myopathy: We selected TSC22D3 and SGK1 because (1) of their opposing Dex response in our MM cell lines (Supplementary Fig.S1), (2); studies indicate anti-proliferative actions (TSC22D3) [39] or pro-survival effects (SGK1) [41], and (3); the receptors themselves were below the detection limit as assessed by RT-qPCR.